XML 56 R7.htm IDEA: XBRL DOCUMENT v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
Cash Flows From Operating Activities:      
Net Loss $ (7,983,738) $ (8,678,347)  
Adjustments To Reconcile Net Loss To Net Cash Used In Operating Activities:      
Depreciation and Amortization 209,367 187,527  
Stock-based Compensation 934,846 1,517,302  
Increase in Inventory Reserves 0 11,000  
Amortization of Right of Use Asset 390,517 478,442  
Amortization of Debt Financing Costs and Accretion of Debt Discount 15,262 0  
Realized (Gain) on Sale of Investments Available-for-Sale (1,929) (13,888)  
Foreign Currency Translation Adjustment 5,611 (92)  
Changes in Assets and Liabilities:      
(Increase) Decrease in Accounts Receivable, net (384,024) 268,104  
Decrease in Insurance Receivable 0 371,217  
(Increase) Decrease in Inventory (827,861) 162,208  
Decrease in Prepaid and Other Assets 1,092,529 203,982  
Increase in Accounts Payable 104,757 30,154  
Decrease in Settlement Payable (47,000) (249,999)  
Decrease in Lease Liability (338,668) (467,440)  
Increase in Other Liabilities 737,937 1,319,375  
Decrease in Deferred License Revenue (446,036) (563,217)  
Changes in Assets and Liabilities (108,366) 1,074,384  
Cash Used In Operating Activities (6,538,430) (5,423,672)  
Cash Flows From Investing Activities:      
Purchase of Investments Available-for-Sale (8,871,583) (8,812,954)  
Sale of Investments Available-for-Sale 11,660,692 12,761,519  
Purchase of Equipment (202,753) (121,826)  
Purchase of Research and Development Licenses (Related Party) 0 (250,000)  
Cash Provided By Investing Activities 2,586,356 3,576,739  
Cash Flows From Financing Activities:      
Proceeds from Term Loan 22,500,000 0  
Debt Issuance Costs (374,043) 0  
Payments on Short Term Note Payable (572,566) 0  
Proceeds from the Issuance of Common Stock / Public Offering 8,147,871 0 $ 5,383,079
Offering Costs from the Issuance of Common Stock / Public Offering (143,913) 0 (309,479)
Proceeds from the Exercise of Employee Stock Options 0 147,900  
Repurchase of Common Shares to Pay Employee Withholding Taxes 0 (95,429)  
Cash Provided By Financing Activities 29,557,349 52,471  
Increase (Decrease) In Cash and Cash Equivalents 25,605,275 (1,794,462)  
Cash At Beginning Of Period 11,794,526 22,713,980 22,713,980
Cash At End Of Period 37,399,801 20,919,518 $ 11,794,526
Supplemental Disclosure of Cash Flow Information:      
Cash Paid for Interest 80,908 0  
Supplemental Disclosure of Noncash Investing and Financing Activities:      
Change in Unrealized Loss on Marketable Securities Available-for-Sale (6,710) (7,161)  
Delivery of Common Stock Underlying Restricted Stock Units 0 273,830  
Issuance Costs related to Debt Financing, not yet paid 956,782 0  
Fair Value of Warrants issued related to Debt Financing $ 500,736 $ 0